WWEX Group Celebrates Carrier Excellence With 2026 Carrier Awards
Honorees exemplify the collaboration and reliability powering WWEX Group's nationwide carrier network.
"Strong carrier relationships are the foundation of our ability to serve shippers at scale," said
This year's winners, which were named at the WWEX Group Partner Channel Conference on
- West Coast LTL Carrier of the Year – Estes
- National LTL Carrier of the Year – XPO
- LTL Carrier Partner of the Year – R&L Carriers
- Southeast LTL Carrier of the Year – ACT Logistics
- Midwest LTL Carrier of the Year – Dayton Freight
- Northwest LTL Carrier of the Year –
PITT OHIO - Partner of the Year – UPS®
WWEX Group supports shippers through a carefully vetted carrier network that spans more than
"The future of logistics is built on collaboration," said Grayson. "As supply chains become more complex, success depends on partners who are willing to work together, adapt quickly and hold each other to a higher standard. Our carrier relationships are central to building a stronger, more resilient network for the long term."
About WWEX Group
The WWEX Group family of brands, which includes Worldwide Express, GlobalTranz, Unishippers, JEAR Logistics and BLX Logistics, offers full-service logistics expertise to 130,000+ customers nationwide while helping move 70 million+ shipments per year. With access to industry-leading small package, truckload, less-than-truckload and managed transportation solutions, customers benefit from enhanced visibility and value across their supply chains.
In 2025, the company reported annual systemwide revenue of approximately
To learn more about WWEX Group, visit www.wwexgroup.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/wwex-group-celebrates-carrier-excellence-with-2026-carrier-awards-302670381.html
SOURCE WWEX Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beverly Hills Plastic Surgeon Dr. David Sayah Reports Growing Demand for Breast Implant Removal and BBL Reversal
- MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for Mucopolysaccharidosis Type IIIB
- U.S. Compliance Expands Chicago Presence to Meet Growing Safety and Environmental Compliance Demand
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share